Prevail Therapeutics (PRVL) Short Interest Ratio & Short Volume → The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad) Free PRVL Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Prevail Therapeutics Short Interest DataCurrent Short Volume1,010,000 sharesPrevious Short Volume1,100,000 sharesChange Vs. Previous Month-8.18%Dollar Volume Sold Short$23.25 millionShort Interest Ratio / Days to Cover2.6Last Record DateDecember 31, 2020Outstanding Shares34,246,000 sharesFloat Size26,920,000 sharesShort Percent of Float3.75%Today's Trading Volume0 sharesAverage Trading Volume955,800 sharesToday's Volume Vs. Average0% Short Selling Prevail Therapeutics ? Sign up to receive the latest short interest report for Prevail Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPRVL Short Interest Over TimePRVL Days to Cover Over TimePRVL Percentage of Float Shorted Over Time Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Prevail Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/20201,010,000 shares $23.25 million -8.2%3.8%2.6 $23.02 12/15/20201,100,000 shares $13.75 million -47.6%3.9%2.9 $12.50 11/30/20202,100,000 shares $21.06 million +1.5%7.5%13.9 $10.03 11/15/20202,070,000 shares $20.20 million -0.5%7.4%13.6 $9.76 10/30/20202,080,000 shares $20.70 million +9.5%7.4%13.3 $9.95 10/15/20201,900,000 shares $19.61 million -1.6%6.8%11.9 $10.32 Get the Latest News and Ratings for PRVL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Prevail Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 9/30/20201,930,000 shares $19.65 million +3.2%6.9%13.7 $10.18 9/15/20201,870,000 shares $22.44 million -0.5%6.7%14.2 $12.00 8/31/20201,880,000 shares $23.03 million -2.1%6.7%12.2 $12.25 8/14/20201,920,000 shares $24.77 million -8.1%6.9%10 $12.90 7/31/20202,090,000 shares $31.29 million +1.5%7.5%10.7 $14.97 7/15/20202,060,000 shares $29.40 million -1.4%7.4%11.3 $14.27 6/30/20202,090,000 shares $31.14 million +11.2%7.5%11.7 $14.90 6/15/20201,880,000 shares $29.31 million +37.2%6.7%10.3 $15.59 5/29/20201,370,000 shares $23.14 million +11.4%4.9%7.3 $16.89 5/15/20201,230,000 shares $18.29 million +2.5%4.4%7.4 $14.87 4/30/20201,200,000 shares $18.38 million -1.6%4.4%7.9 $15.32 4/15/20201,220,000 shares $16.23 million +8.9%4.4%8.2 $13.30 3/31/20201,120,000 shares $13.65 million +7.9%4.1%7.1 $12.19 3/13/20201,037,800 shares $14.85 million +1.8%N/A8 $14.31 2/28/20201,020,000 shares $13.04 million +9.8%N/A7.7 $12.78 2/14/2020929,300 shares $16.17 million +39.6%3.4%7.5 $17.40 1/31/2020665,900 shares $12.59 million -1.7%2.4%5.7 $18.90 1/15/2020677,100 shares $11.54 million -9.6%2.4%6.2 $17.04 12/31/2019748,800 shares $11.82 million +2.6%2.6%7.5 $15.79 PRVL Short Interest - Frequently Asked Questions What is Prevail Therapeutics' current short interest? Short interest is the volume of Prevail Therapeutics shares that have been sold short but have not yet been closed out or covered. As of December 31st, investors have sold 1,010,000 shares of PRVL short. 3.75% of Prevail Therapeutics' shares are currently sold short. Learn More on Prevail Therapeutics' current short interest. What is a good short interest ratio for Prevail Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PRVL shares currently have a short interest ratio of 3.0. Learn More on Prevail Therapeutics's short interest ratio. What is a good short interest percentage for Prevail Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.75% of Prevail Therapeutics' floating shares are currently sold short. Is Prevail Therapeutics' short interest increasing or decreasing? Prevail Therapeutics saw a decrease in short interest in December. As of December 31st, there was short interest totaling 1,010,000 shares, a decrease of 8.2% from the previous total of 1,100,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Prevail Therapeutics' float size? Prevail Therapeutics currently has issued a total of 34,246,000 shares. Some of Prevail Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Prevail Therapeutics currently has a public float of 26,920,000 shares. How does Prevail Therapeutics' short interest compare to its competitors? 3.75% of Prevail Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Prevail Therapeutics: REGENXBIO Inc. (8.30%), Relay Therapeutics, Inc. (8.08%), CARGO Therapeutics, Inc. (13.21%), Cullinan Oncology, Inc. (6.38%), Immatics (10.60%), Mesoblast Limited (0.63%), BioCryst Pharmaceuticals, Inc. (16.68%), Cabaletta Bio, Inc. (21.09%), HilleVax, Inc. (2.83%), Novavax, Inc. (31.28%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($6.95 billion), Aon plc ($4.44 billion), Analog Devices, Inc. ($4.13 billion), Snap Inc. ($3.12 billion), Peloton Interactive, Inc. ($2.68 billion), Moderna, Inc. ($2.60 billion), The Clorox Company ($2.47 billion), The Kroger Co. ($2.32 billion), International Flavors & Fragrances Inc. ($2.21 billion), and Altice USA, Inc. ($1.94 billion). View all of the most shorted stocks. What does it mean to sell short Prevail Therapeutics stock? Short selling PRVL is an investing strategy that aims to generate trading profit from Prevail Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Prevail Therapeutics? A short squeeze for Prevail Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PRVL, which in turn drives the price of the stock up even further. How often is Prevail Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PRVL, twice per month. The most recent reporting period available is December, 31 2020. More Short Interest Resources from MarketBeat Related Companies: REGENXBIO Short Interest Data Relay Therapeutics Short Interest Data CARGO Therapeutics Short Interest Data Cullinan Oncology Short Interest Data Immatics Short Interest Data Mesoblast Short Interest Data BioCryst Pharmaceuticals Short Interest Data Cabaletta Bio Short Interest Data HilleVax Short Interest Data Novavax Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PRVL) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals